Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide
详细信息 查看全文
- 作者：Vicente Villanueva ; Francisco Javier L¨®pez ; Jos¨¦ Mar¨ªa Serratosa ; Beatriz Gonz¨¢lez-Giraldez ; Dulce Campos ; Albert Molins ; Juan Rodriguez Uranga ; Jos¨¦ Angel Mauri ; Javier Salas-Puig ; Manuel Toledo ; Juan Carlos S¨¢nchez-Alvarez ; Antonio Moreno ; Pedro J. Serrano-Castro ; Rosa Ana Saiz-Diaz ; Jes¨²s Gonz¨¢lez de la Aleja ; Pilar de la Pe?a ; Montserrat Asensio
- 关键词：Focal epilepsy ; Seizure-free ; Lacosamide ; Antiepileptic drugs ; Retrospective study
- 刊名：Epilepsy & Behavior
- 出版年：2013
- 出版时间：November, 2013
- 年：2013
- 卷：29
- 期：2
- 页码：349-356
- 全文大小：415 K
文摘
Lacosamide is approved as adjunctive therapy for focal epilepsies. The number of antiepileptic drugs (AEDs) tried is associated with prognosis. This multicenter, retrospective, observational study (LACO-EXP) in Spain in 500 adult patients with focal epilepsies examined the efficacy and tolerability of add-on lacosamide. Factors associated with better efficacy/tolerability were analyzed. After 12 months, the responder rate (¡Ý 50 % reduction in seizure frequency) was 57.1 % , and the seizure-free rate was 14.9 % . Efficacy was better when lacosamide was the first or second add-on AED, although there was a small chance to be seizure-free even for patients who had received ¡Ü 10 prior AEDs. The mechanism of action of concomitant AEDs is important in all the stages, but differences are smaller in the early stages. Lacosamide was generally well tolerated. A slower dosage-titration schedule was associated with a lower adverse event rate. Further investigation of the timing of initiation of lacosamide add-on therapy and ideal combinations of AEDs is required.